Literature DB >> 17567642

Commentary: prostate cancer is omnipresent, but should we screen for it?

Richard M Martin1.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17567642      PMCID： PMC2764984          DOI： 10.1093/ije/dym049

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN： 0300-5771            Impact factor:   7.196


× No keyword cloud information.
  25 in total

1.  Latent carcinoma of the prostate.

Authors:  L M FRANKS
Journal:  J Pathol Bacteriol       Date:  1954-10

2.  Data dredging, bias, or confounding.

Authors:  George Davey Smith; Shah Ebrahim
Journal:  BMJ       Date:  2002-12-21

3.  Radical prostatectomy versus watchful waiting in early prostate cancer.

Authors:  Anna Bill-Axelson; Lars Holmberg; Mirja Ruutu; Michael Häggman; Swen-Olof Andersson; Stefan Bratell; Anders Spångberg; Christer Busch; Stig Nordling; Hans Garmo; Juni Palmgren; Hans-Olov Adami; Bo Johan Norlén; Jan-Erik Johansson
Journal:  N Engl J Med       Date:  2005-05-12       Impact factor: 91.245

4.  Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.

Authors:  Ian M Thompson; Donna Pauler Ankerst; Chen Chi; M Scott Lucia; Phyllis J Goodman; John J Crowley; Howard L Parnes; Charles A Coltman
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

5.  A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995.

Authors:  P C Albertsen; S Walters; J A Hanley
Journal:  J Urol       Date:  2000-02       Impact factor: 7.450

Review 6.  Screening for prostate cancer.

Authors:  Stephen Frankel; George Davey Smith; Jenny Donovan; David Neal
Journal:  Lancet       Date:  2003-03-29       Impact factor: 79.321

Review 7.  Prostate cancer epidemiology.

Authors:  Henrik Grönberg
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

8.  A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival.

Authors:  C Parker; D Muston; J Melia; S Moss; D Dearnaley
Journal:  Br J Cancer       Date:  2006-05-22       Impact factor: 7.640

Review 9.  Prostate cancer: screening approaches.

Authors:  J L Donovan; R M Martin; D E Neal; F C Hamdy
Journal:  Br J Hosp Med (Lond)       Date:  2005-11       Impact factor: 0.825

10.  Does current evidence justify prostate cancer screening in Europe?

Authors:  Richard M Martin; George Davey Smith; Jenny Donovan
Journal:  Nat Clin Pract Oncol       Date:  2005-11
View more
  2 in total

1.  Incidence of prostate, breast, lung and colorectal cancer following new consultation for musculoskeletal pain: a cohort study among UK primary care patients.

Authors:  Kelvin P Jordan; Richard A Hayward; Milisa Blagojevic-Bucknall; Peter Croft
Journal:  Int J Cancer       Date:  2013-02-25       Impact factor: 7.396

2.  Prostate cancer screening in a low prevalence population. Is it worth it?

Authors:  Mostafa A Arafa; Karim H Farhat; Mohamed A Al-Atawi; Danny M Rabah
Journal:  Saudi Med J       Date:  2017-07       Impact factor: 1.484
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.